Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Bethesda North Marriott Hotel and Conference Center

Apr 09, 2014 7:00 AM - Apr 10, 2014 5:45 PM

5701 Marinelli Road, , North Bethesda, MD 20852 , USA

Global Labeling 2014: Compliance in a Changing Regulatory Environment

Session 7 - Hot Topics in Canada

Session Chair(s)

Mark  Collins, PhD, MBA

Mark Collins, PhD, MBA

Principal Consultant

Opus Regulatory, United States

In this session, plain language labeling will be discussed. Speakers will highlight the draft, published regulations concerning plain language labeling, an attempt to make drug labeling understandable by focusing on five targeted amendments which will provide: 1) a requirement for clear understandable, plain language labels; 2) required label mock-ups at time of review; 3) look-alike, sound-alike brand name assessments; 4) label contact information to report problems; and 5) a standard table format for key label information for nonprescription drugs. This session will also cover the final guidance, Labeling of Pharmaceutical Drugs for Human Use, highlighting changes from the 2010 draft and key points.

Speaker(s)

Bruce  Boulton, MSc

Hot Topics in Canada: Draft Plain Language Labeling Regulations

Bruce Boulton, MSc

Health Canada, Canada

Product Information Officer, Bureau Gastroenterology, Infection & Viral Diseases

Bruce  Boulton, MSc

Final Guidance – Labeling of Pharmaceutical Drugs for Human Use

Bruce Boulton, MSc

Health Canada, Canada

Product Information Officer, Bureau Gastroenterology, Infection & Viral Diseases

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.